We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Cites CareFore for cGMP, MDR Deficiencies
FDA Cites CareFore for cGMP, MDR Deficiencies
March 2, 2006
The FDA sent a Jan. 10 warning letter to CareFore Medical for failure to conform to current good manufacturing practice (cGMP) requirements of the Quality System (QS) regulation, and failure to develop medical device reporting procedures.